查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1957350

2026年全球体外肺部模型市场报告

In-Vitro Lung Model Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外肺模型市场发展迅速。预计该市场规模将从2025年的5.4亿美元成长到2026年的6.5亿美元，复合年增长率达21.0%。这一增长归因于多种因素，例如动物模型在呼吸系统研究中的局限性、二维肺细胞培养技术的长期应用、呼吸系统疾病研究活动的增加、学术界肺生物学研究的发展以及基于类器官的研究方法的早期应用。

预计未来几年体外肺模型市场将快速成长，到2030年将达到12.9亿美元，复合年增长率（CAGR）为18.6%。预测期内的成长要素包括：对可预测的临床前肺模型的需求不断增长；人们越来越重视减少动物试验；呼吸系统药物开发平臺不断扩展；对先进体外研究工具的投资增加；以及对更俱生理相关性的肺部疾病模型的需求。预测期内的主要趋势包括：药物研究中三维肺模型的应用日益广泛；肺晶片平台在疾病建模中的应用日益广泛；对高度人体相关的体外肺测试系统的需求日益增长；体外肺模型在毒理学和安全性测试中的应用日益广泛；以及体外肺模型在临床前研究管线中的整合程度不断提高。

预计未来几年，体外肺模型市场的成长将主要受临床研究增加的推动。临床研究旨在评估新型医疗程序、药物和诊断工具在人体内的安全性、有效性和疗效。由于医疗需求不断增长、对先进医疗疗法的需求日益增加，以及为复杂疾病开发创新解决方案的持续努力，临床研究的数量正在增加。体外肺模型市场透过提供一个受控系统来支持临床研究，有助于药物筛检、毒性评估、疾病建模以及肺部特异性生物反应的评估。例如，根据美国临床试验註册网站ClinicalTrials.gov的数据，截至2024年1月，全球註册的临床试验数量预计到2023年底将达到477,230项，高于2022年的437,508项。因此，临床研究的增加正在推动体外肺模型市场的成长。

体外肺模型市场的主要企业正致力于开发先进的三维（3D）呼吸组织模型，以提高生理相关性、增强预测准确性并强化临床前试验能力。 3D呼吸组织模型是实验室设计的三维结构，由在模拟人体呼吸道组织结构和功能的条件下培养的原代或特化呼吸细胞构成，包括粘液分泌、纤毛活动和屏障功能的完整性。例如，2023年4月，美国生物技术公司MatTek Corporation宣布推出“EpiNasal”，这是一种由人类原代鼻上皮细胞开发的3D呼吸组织模型。该模型模拟了鼻上皮的关键特征，例如杯状细胞、功能性紧密连接和运动纤毛，为研究人员提供了一个高度相关的平台，用于研究药物、化学物质、病原体和消费品对人体呼吸组织的影响。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球体外肺模型市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 药物研究中三维肺模型的应用日益增多
    • 扩大晶片肺平台在疾病建模的应用
    • 人们越来越倾向于选择与人体相关的体外肺部测试系统。
    • 扩大体外肺模型在毒理学和安全性测试的应用
    • 加强体外肺模型在非临床研究流程的整合。

第五章 终端用户产业市场分析

  • 学术研究机构
  • 製药公司
  • 生技公司
  • 合约研究组织（CRO）
  • 政府研究机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球体外肺模型市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球体外肺模型市场规模、比较及成长率分析
  • 全球体外肺模型市场表现：规模与成长，2020-2025年
  • 全球体外肺模型市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按类型
  • 二维模型、三维模型
  • 透过使用
  • 药物发现与毒理学研究、生理学研究、三维（3D）模型开发及其他应用。
  • 最终用户
  • 学术研究机构、製药和生物技术公司以及其他最终用户
  • 按类型细分：二维 (2D) 模型
  • 单层细胞培养、共培养
  • 按类型细分：三维 (3D) 模型
  • 球状体、类器官、晶片肺模型

第十章 区域与国别分析

  • 全球体外肺模型市场：按地区划分，实际结果和预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球体外肺模型市场：依国家划分，实际结果及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 体外肺模型市场：竞争格局及市场占有率（2024年）
  • 体外肺模型市场：公司估值矩阵
  • 体外肺模型市场：公司概况
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • PerkinElmer Inc.
    • Charles River Laboratories International Inc.
    • Epithelix

第37章 其他大型企业和创新企业

  • STEMCELL Technologies, American Type Culture Collection（ATCC）, BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical KK, 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年体外肺模型市场：提供新机会的国家
  • 2030年体外肺模型市场：新兴细分市场机会
  • 2030年体外肺部模型市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH3MIVLM01_G26Q1

An in vitro lung model is a laboratory-based scientific system designed to replicate the cellular, structural, and functional characteristics of the human lung under controlled conditions. These models allow researchers to study disease progression, identify biomarkers, and evaluate the effectiveness of treatments. They serve as valuable tools for advancing the understanding of lung biology, supporting therapy development, and improving overall health outcomes.

The main types of in vitro lung models include two-dimensional (2D) models and three-dimensional (3D) models. A 2D model is a simplified representation of lung cells and tissues cultured on a flat surface and is commonly used in basic research and early-stage substance testing. These models are applied across various areas such as drug discovery, toxicology studies, physiological research, three-dimensional (3D) model development, and others, and are utilized by academic research institutes, pharmaceutical and biotechnology companies, and other end users.

Tariffs have impacted the in-vitro lung model market by increasing the cost of imported microfluidic components, laboratory instruments, and specialized cell culture materials used in advanced lung model systems. These effects have been most evident in lung-on-a-chip and three-dimensional model segments, particularly in North America and Europe where high-precision components are often sourced internationally. Asia-Pacific markets have experienced procurement delays due to trade dependencies. However, tariffs have encouraged regional manufacturing of research equipment and localized sourcing of consumables, supporting long-term supply chain resilience.

The in-vitro lung model market research report is one of a series of new reports from The Business Research Company that provides in-vitro lung model market statistics, including in-vitro lung model industry global market size, regional shares, competitors with a in-vitro lung model market share, detailed in-vitro lung model market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro lung model industry. This in-vitro lung model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro lung model market size has grown exponentially in recent years. It will grow from $0.54 billion in 2025 to $0.65 billion in 2026 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to limitations of animal models in respiratory research, longstanding use of two-dimensional lung cell cultures, increasing respiratory disease research activity, growth in academic lung biology research, early adoption of organoid-based research methods.

The in-vitro lung model market size is expected to see rapid growth in the next few years. It will grow to $1.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to rising demand for predictive preclinical lung models, increasing focus on reducing animal testing, expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, demand for more physiologically relevant lung disease models. Major trends in the forecast period include increasing adoption of three-dimensional lung models in drug research, growing use of lung-on-a-chip platforms for disease modeling, rising preference for human-relevant in-vitro lung testing systems, expansion of in-vitro lung models in toxicology and safety studies, greater integration of in-vitro lung models in preclinical research pipelines.

The growing number of clinical studies is expected to drive the growth of the in vitro lung model market in the coming years. Clinical studies are research investigations carried out to assess the safety, efficacy, and outcomes of new medical treatments, drugs, or diagnostic tools in humans. The volume of clinical studies is increasing due to rising healthcare demands, greater need for advanced medical therapies, and ongoing efforts to develop innovative solutions for complex health conditions. The in vitro lung model market supports clinical research by providing controlled systems that facilitate drug screening, toxicity assessment, disease modeling, and the evaluation of lung-specific biological responses. For example, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,230 registered clinical trials worldwide by the end of 2023, up from 437,508 trials in 2022. Therefore, the rise in clinical studies is contributing to the growth of the in vitro lung model market.

Major companies operating in the in vitro lung model market are concentrating on the development of advanced three-dimensional (3D) respiratory tissue models to enhance physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model is a laboratory-engineered, three-dimensional structure composed of primary or specialized respiratory cells cultured under conditions that replicate the structure and function of human airway tissues, including mucus secretion, ciliary activity, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, launched EpiNasal, a 3D respiratory tissue model developed from primary human nasal epithelial cells. This model reproduces key features of nasal epithelium such as goblet cells, functional tight junctions, and motile cilia, offering researchers a highly relevant platform to study the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

In July 2024, Tergus Pharma, a US-based end-to-end service provider for topical pharmaceutical products, merged with MedPharm Ltd. for an undisclosed amount. This merger enhances Tergus Pharma's integrated development and manufacturing capabilities by combining MedPharm's strengths in formulation development, in vitro performance testing, and human tissue-based delivery models with Tergus's expertise in commercial manufacturing and serialization. It also expands the company's capacity to develop and manufacture hormone-based and highly potent drugs through increased GMP capabilities at its Durham, North Carolina facility. MedPharm Ltd. is a UK-based company that provides in vitro models simulating lung and nasal drug-delivery systems.

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro lung model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Lung Model Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in-vitro lung model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro lung model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro lung model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Two-Dimensional (2D) Model; Three-Dimensional (3D) Model
  • 2) By Application: Drug Discovery And Toxicology Studies; Physiological Research; Three-Dimensional (3D) Model Development; Other Applications
  • 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures; Co-cultures
  • 2) By Three-Dimensional (3D) Model: Spheroids; Organoids; Lung-On-A-chip Models
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; PerkinElmer Inc.; Charles River Laboratories International Inc.; Epithelix; STEMCELL Technologies; American Type Culture Collection (ATCC); BioIVT; InSphero; Emulate Inc.; PhoenixBio Co. Ltd.; Newcells Biotech; CN Bio Innovations Ltd.; Mimetas; Cyfuse Biomedical K.K.; 3D Biotek LLC; AlveoliX AG; Hesperos Inc.; SynVivo Inc.; VITROCELL Systems GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In-Vitro Lung Model Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In-Vitro Lung Model Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In-Vitro Lung Model Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In-Vitro Lung Model Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Three-Dimensional Lung Models In Drug Research
    • 4.2.2 Growing Use Of Lung-On-A-Chip Platforms For Disease Modeling
    • 4.2.3 Rising Preference For Human-Relevant In-Vitro Lung Testing Systems
    • 4.2.4 Expansion Of In-Vitro Lung Models In Toxicology And Safety Studies
    • 4.2.5 Greater Integration Of In-Vitro Lung Models In Preclinical Research Pipelines

5. In-Vitro Lung Model Market Analysis Of End Use Industries

  • 5.1 Academic Research Institutes
  • 5.2 Pharmaceutical Companies
  • 5.3 Biotechnology Companies
  • 5.4 Contract Research Organizations (Cros)
  • 5.5 Government Research Laboratories

6. In-Vitro Lung Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In-Vitro Lung Model Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In-Vitro Lung Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In-Vitro Lung Model Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In-Vitro Lung Model Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In-Vitro Lung Model Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In-Vitro Lung Model Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In-Vitro Lung Model Market Segmentation

  • 9.1. Global In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
  • 9.2. Global In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
  • 9.3. Global In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
  • 9.4. Global In-Vitro Lung Model Market, Sub-Segmentation Of Two-Dimensional (2D) Model, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Monolayer Cell Cultures, Co-cultures
  • 9.5. Global In-Vitro Lung Model Market, Sub-Segmentation Of Three-Dimensional (3D) Model, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spheroids, Organoids, Lung-On-A-chip Models

10. In-Vitro Lung Model Market Regional And Country Analysis

  • 10.1. Global In-Vitro Lung Model Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In-Vitro Lung Model Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In-Vitro Lung Model Market

  • 11.1. Asia-Pacific In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In-Vitro Lung Model Market

  • 12.1. China In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In-Vitro Lung Model Market

  • 13.1. India In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In-Vitro Lung Model Market

  • 14.1. Japan In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In-Vitro Lung Model Market

  • 15.1. Australia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In-Vitro Lung Model Market

  • 16.1. Indonesia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In-Vitro Lung Model Market

  • 17.1. South Korea In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In-Vitro Lung Model Market

  • 18.1. Taiwan In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In-Vitro Lung Model Market

  • 19.1. South East Asia In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In-Vitro Lung Model Market

  • 20.1. Western Europe In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In-Vitro Lung Model Market

  • 21.1. UK In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In-Vitro Lung Model Market

  • 22.1. Germany In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In-Vitro Lung Model Market

  • 23.1. France In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In-Vitro Lung Model Market

  • 24.1. Italy In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In-Vitro Lung Model Market

  • 25.1. Spain In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In-Vitro Lung Model Market

  • 26.1. Eastern Europe In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In-Vitro Lung Model Market

  • 27.1. Russia In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In-Vitro Lung Model Market

  • 28.1. North America In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In-Vitro Lung Model Market

  • 29.1. USA In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In-Vitro Lung Model Market

  • 30.1. Canada In-Vitro Lung Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In-Vitro Lung Model Market

  • 31.1. South America In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In-Vitro Lung Model Market

  • 32.1. Brazil In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In-Vitro Lung Model Market

  • 33.1. Middle East In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In-Vitro Lung Model Market

  • 34.1. Africa In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In-Vitro Lung Model Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In-Vitro Lung Model Market Regulatory and Investment Landscape

36. In-Vitro Lung Model Market Competitive Landscape And Company Profiles

  • 36.1. In-Vitro Lung Model Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In-Vitro Lung Model Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In-Vitro Lung Model Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Epithelix Overview, Products and Services, Strategy and Financial Analysis

37. In-Vitro Lung Model Market Other Major And Innovative Companies

  • STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

38. Global In-Vitro Lung Model Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In-Vitro Lung Model Market

40. In-Vitro Lung Model Market High Potential Countries, Segments and Strategies

  • 40.1 In-Vitro Lung Model Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In-Vitro Lung Model Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In-Vitro Lung Model Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer